354 related articles for article (PubMed ID: 7051989)
1. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
Kallenberg CG; Pastoor GW; Wouda AA; The TH
Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
[TBL] [Abstract][Full Text] [Related]
2. [Raynaud's phenomenon and anticentromere antibodies].
Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
[No Abstract] [Full Text] [Related]
3. Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies.
Kallenberg CG; van der Meulen J; Pastoor GW; Snijder JA; Feltkamp TE; The TH
Scand J Rheumatol; 1983; 12(3):193-200. PubMed ID: 6414079
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
5. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
6. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
7. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
[TBL] [Abstract][Full Text] [Related]
8. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
9. A long-term longitudinal study of anticentromere antibodies.
Tramposch HD; Smith CD; Senecal JL; Rothfield N
Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
[TBL] [Abstract][Full Text] [Related]
10. Significance of anticentromere antibody in idiopathic Raynaud's syndrome.
Sarkozi J; Bookman AA; Lee P; Keystone EC; Fritzler MJ
Am J Med; 1987 Nov; 83(5):893-8. PubMed ID: 3314499
[TBL] [Abstract][Full Text] [Related]
11. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
Fritzler MJ; Kinsella TD
Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
[TBL] [Abstract][Full Text] [Related]
12. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.
Kallenberg CG; Wouda AA; Hoet MH; van Venrooij WJ
Ann Rheum Dis; 1988 Aug; 47(8):634-41. PubMed ID: 3261966
[TBL] [Abstract][Full Text] [Related]
13. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
Goldman JA
Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
[TBL] [Abstract][Full Text] [Related]
14. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
[TBL] [Abstract][Full Text] [Related]
15. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
Earnshaw W; Bordwell B; Marino C; Rothfield N
J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
[TBL] [Abstract][Full Text] [Related]
16. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of patients with anticentromere antibody.
Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.
Cruz M; Mejia G; Lavalle C; Cortes JJ; Reyes PA
Clin Rheumatol; 1988 Mar; 7(1):80-6. PubMed ID: 3261675
[TBL] [Abstract][Full Text] [Related]
20. [Antinuclear antibodies in primary biliary cirrhosis].
Mzali S; Johanet C; Chrétien P; Abuaf N
Gastroenterol Clin Biol; 1989; 13(8-9):690-5. PubMed ID: 2680726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
